NCT02684032 2022-07-27A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast CancerCelcuity IncPhase 1 Completed141 enrolled